Dyslipidaemias result in the deposition of cholesterol and lipids in the walls of blood vessels,
chronic inflammation and the formation of atherosclerotic plaques, which impede blood flow …

In recent years, there has been growing interest in the possible use of nutraceuticals to
improve and optimize dyslipidemia control and therapy. Based on the data from available …

Atherosclerosis is a chronic inflammatory disease affecting large and medium arteries and is
considered to be a major underlying cause of cardiovascular disease (CVD). Although the …

Background: The use of nutraceutical products and functional foods in the cardiovascular
and metabolic field is rising in several countries. Preparation and implementation of …

Currently, the nutraceutical approach to treat dyslipidaemia is increasing in use, and in
many cases is used by physicians as the first choice in the treatment of patients with …

Growing attention is now being given to the possible preventive/alternative ways to avoid
illness onset. Changes in lifestyle and food habits are taking over from the conventional …

Cardiovascular disease (CVD) ranks among the most common health-related and economic
issues worldwide. Dietary factors are important contributors to cardiovascular risk, either …

Hypercholesterolemia is a well-established modifiable cardiovascular risk factor and its
treatment is an essential aim in preventing cardiovascular disease. Current guidelines …

J Clin Hypertens (Greenwich). 2012; 14: 121–132.© 2012 Wiley Periodicals, Inc. The
combination of a lipid‐lowering diet and scientifically proven nutraceutical supplements has …

Coronary heart disease (CHD) is the main cause of death and morbidity in the world.
Childhood is a critical period during which atherosclerosis may begin to develop; in the …